tranexamic acid has been researched along with Aortic Aneurysm in 12 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Aortic Aneurysm: An abnormal balloon- or sac-like dilatation in the wall of AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 5.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
| " We present a case of postmenopausal bleeding, because of chronic DIC, which resulted from aortic aneurysm and was managed with replacement blood products and tranexamic acid." | 3.72 | Postmenopausal bleeding due to chronic DIC. ( Bollapragada, SS; Garg, M; McFarlane, T, 2004) |
| "Tranexamic acid treatment was without side effects and was given in standard doses until closure of the aneurysm or alternatively up to three days after the initial bleeding." | 2.43 | ["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid]. ( Astrup, J, 2006) |
| "The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 1.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
| "Enhanced CT revealed type-A acute aortic dissection." | 1.28 | [A case of medically treated type A acute aortic dissection: trial of antifibrinolytic therapy while monitoring the thrombotic and fibrinolytic parameters]. ( Hamanaka, S; Hata, T; Murakami, T; Namba, H; Shinozaki, M; Sone, Y; Taniguchi, G; Tezuka, M; Tsushima, Y, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monaco, F | 1 |
| Nardelli, P | 1 |
| Pasin, L | 1 |
| Barucco, G | 1 |
| Mattioli, C | 1 |
| Di Tomasso, N | 1 |
| Dalessandro, G | 1 |
| Giardina, G | 1 |
| Landoni, G | 2 |
| Chiesa, R | 1 |
| Zangrillo, A | 2 |
| Bolliger, D | 2 |
| Tanaka, KA | 2 |
| Yamada, S | 1 |
| Asakura, H | 1 |
| Gatate, Y | 1 |
| Masaki, N | 1 |
| Sato, A | 1 |
| Yasuda, R | 1 |
| Namba, T | 1 |
| Yada, H | 1 |
| Kawamura, A | 1 |
| Adachi, T | 1 |
| Silvetti, S | 1 |
| Crivellari, M | 1 |
| Castiglioni, A | 1 |
| Alfieri, O | 1 |
| Koster, A | 1 |
| Faraoni, D | 1 |
| Kimura, SI | 1 |
| Odawara, J | 1 |
| Aoki, T | 1 |
| Yamakura, M | 1 |
| Takeuchi, M | 1 |
| Watanabe, Y | 1 |
| Matsue, K | 1 |
| Diplaris, KT | 1 |
| Karfis, EA | 1 |
| Ampatzidou, F | 1 |
| Ananiadou, OG | 1 |
| Vakalopoulou, S | 1 |
| Madesis, A | 1 |
| Asteri, T | 1 |
| Drossos, G | 1 |
| Bollapragada, SS | 1 |
| Garg, M | 1 |
| McFarlane, T | 1 |
| Astrup, J | 1 |
| Tsushima, Y | 1 |
| Hata, T | 1 |
| Namba, H | 1 |
| Sone, Y | 1 |
| Tezuka, M | 1 |
| Shinozaki, M | 1 |
| Murakami, T | 1 |
| Hamanaka, S | 1 |
| Taniguchi, G | 1 |
| Takada, A | 1 |
| Takada, Y | 1 |
| Mori, T | 1 |
| Sakaguchi, S | 1 |
| Tomeoku, M | 1 |
| Nakase, T | 1 |
| Morita, K | 1 |
| Katou, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma[NCT05713630] | Phase 3 | 130 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| Tranexamic Acid in Major Vascular Surgery. A Randomized Placebo-controlled Trial.[NCT02335359] | Phase 4 | 100 participants (Actual) | Interventional | 2015-03-04 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for tranexamic acid and Aortic Aneurysm
| Article | Year |
|---|---|
Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Anticoagulants; Antifibrinolytic | 2021 |
["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid].
Topics: Aneurysm, Ruptured; Antifibrinolytic Agents; Aortic Aneurysm; Denmark; Early Diagnosis; Emergencies; | 2006 |
1 trial available for tranexamic acid and Aortic Aneurysm
| Article | Year |
|---|---|
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
9 other studies available for tranexamic acid and Aortic Aneurysm
| Article | Year |
|---|---|
Tranexamic acid in vascular surgery: antifibrinolytic or clot-stabilising activity.
Topics: Antifibrinolytic Agents; Aortic Aneurysm; Humans; Thrombosis; Tranexamic Acid; Vascular Surgical Pro | 2020 |
Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Disseminated Int | 2017 |
CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Blood Coag | 2016 |
Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.
Topics: Aged; Aortic Aneurysm; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Kidney Failure, | 2009 |
Acute type-a dissection in a patient with severe hemophilia A.
Topics: Acute Disease; Aortic Aneurysm; Aortic Dissection; Factor VIII; Hemophilia A; Humans; Male; Middle A | 2012 |
Postmenopausal bleeding due to chronic DIC.
Topics: Aged; Aortic Aneurysm; Blood Transfusion; Chronic Disease; Disseminated Intravascular Coagulation; F | 2004 |
[A case of medically treated type A acute aortic dissection: trial of antifibrinolytic therapy while monitoring the thrombotic and fibrinolytic parameters].
Topics: Acute Disease; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Aortic Aneurysm; Aort | 1992 |
Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.
Topics: Aged; alpha-Macroglobulins; Aorta, Abdominal; Aortic Aneurysm; Cyclohexanecarboxylic Acids; Dissemin | 1990 |
[Chronic disseminated intravascular coagulation due to abdominal true aneurysm in two cases--effect of anti-platelet and anti-fibrinolytic therapy].
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Chronic Disease; Cyclohexanecarboxylic Acids; Disseminated | 1989 |